Each microsphere population carries a distinct fluorescent identity and is coupled to a capture molecule, such as an antibody. When a sample is introduced, targets bind selectively to the appropriate bead population. Flow-based analysis then separates bead identities from reporter signals, allowing several analytes to be recognized within the same measurement rather than treated as one undifferentiated signal.
Capture antibodies provide target selectivity by binding particular proteins to their corresponding microspheres. After this initial binding step, detection antibodies recognize the captured targets and support generation of fluorescent reporter signals. Using these two antibody functions together links each signal to a specific analyte, enabling the system to distinguish and quantify cytokines, chemokines, growth factors, and other measured biomarkers.
Multiplexing allows many biological analytes to be measured from a shared sample instead of allocating separate portions to individual assays. This can improve experimental efficiency and preserve limited material for broader profiling. In medical research, simultaneous measurements also make it possible to examine relationships among biomarkers, which may provide more informative molecular context than evaluating each marker independently.
The workflow begins with color-coded microspheres carrying analyte-specific capture molecules. Targets in the sample bind to the appropriate beads, and detection antibodies are then used to generate fluorescent reporter signals. Flow-based analysis reads bead identity together with the associated fluorescence, producing measurements for multiple analytes in a single sample and supporting subsequent biomarker profile analysis.
The platform can support studies of cytokines, chemokines, growth factors, and other biomarkers relevant to immunology and inflammation. Its multiplex measurements also contribute to disease characterization and therapeutic research. By examining several molecular signals together, investigators can develop broader profiles of biological responses and assess how clinically relevant biomarkers vary as part of a shared experimental context.
A combined profile can reveal patterns across multiple clinically relevant biomarkers rather than focusing on a single measurement. In disease characterization, those patterns may help describe molecular features associated with inflammatory or immune processes. In therapeutic research, the same approach can support evaluation of biomarker responses across a broader panel, while conserving sample volume and improving measurement efficiency.